US Stock MarketDetailed Quotes

TECX Tectonic Therapeutic

Watchlist

18.000
-0.130-0.72%

Close Jul 30 16:00 ET

265.22MMarket Cap-510P/E (TTM)

Tectonic Therapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-121.91%-27.64M

-7.79M

-12.45M

Net income from continuing operations

-260.48%-32.18M

---10.29M

---8.93M

Operating gains losses

90.98%-643K

--0

---7.13M

Depreciation and amortization

176.37%1.01M

--322K

--364K

Other non cash items

80.15%1.23M

--269K

--680K

Change In working capital

-4.18%1.84M

--1.64M

--1.92M

-Change in prepaid assets

-102.15%-376K

---17K

---186K

-Change in payables and accrued expense

54.99%3.28M

--1.92M

--2.11M

-Change in other current assets

-27.27%-14K

--17K

---11K

-Change in other current liabilities

---1.05M

---280K

--0

Cash from discontinued investing activities

Operating cash flow

-121.91%-27.64M

---7.79M

---12.45M

Investing cash flow

Cash flow from continuing investing activities

1.60%-2.09M

-285K

-2.12M

Net PPE purchase and sale

1.60%-2.09M

---285K

---2.12M

Cash from discontinued investing activities

Investing cash flow

1.60%-2.09M

---285K

---2.12M

Financing cash flow

Cash flow from continuing financing activities

-9.15%37.63M

-119K

41.42M

Net issuance payments of debt

-110.88%-393K

---119K

--3.61M

Net preferred stock issuance

0.56%38.02M

--0

--37.81M

Proceeds from stock option exercised by employees

100.00%4K

--0

--2K

Cash from discontinued financing activities

Financing cash flow

-9.15%37.63M

---119K

--41.42M

Net cash flow

Beginning cash position

1,486.38%28.65M

--44.75M

--1.81M

Current changes in cash

-70.56%7.9M

---8.2M

--26.84M

End cash Position

27.58%36.55M

--36.55M

--28.65M

Free cash flow

-103.93%-29.73M

---8.08M

---14.58M

Currency Unit

USD

USD

USD

	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-121.91%-27.64M	-7.79M	-12.45M
Net income from continuing operations	-260.48%-32.18M	---10.29M	---8.93M
Operating gains losses	90.98%-643K	--0	---7.13M
Depreciation and amortization	176.37%1.01M	--322K	--364K
Other non cash items	80.15%1.23M	--269K	--680K
Change In working capital	-4.18%1.84M	--1.64M	--1.92M
-Change in prepaid assets	-102.15%-376K	---17K	---186K
-Change in payables and accrued expense	54.99%3.28M	--1.92M	--2.11M
-Change in other current assets	-27.27%-14K	--17K	---11K
-Change in other current liabilities	---1.05M	---280K	--0
Cash from discontinued investing activities
Operating cash flow	-121.91%-27.64M	---7.79M	---12.45M
Investing cash flow
Cash flow from continuing investing activities	1.60%-2.09M	-285K	-2.12M
Net PPE purchase and sale	1.60%-2.09M	---285K	---2.12M
Cash from discontinued investing activities
Investing cash flow	1.60%-2.09M	---285K	---2.12M
Financing cash flow
Cash flow from continuing financing activities	-9.15%37.63M	-119K	41.42M
Net issuance payments of debt	-110.88%-393K	---119K	--3.61M
Net preferred stock issuance	0.56%38.02M	--0	--37.81M
Proceeds from stock option exercised by employees	100.00%4K	--0	--2K
Cash from discontinued financing activities
Financing cash flow	-9.15%37.63M	---119K	--41.42M
Net cash flow
Beginning cash position	1,486.38%28.65M	--44.75M	--1.81M
Current changes in cash	-70.56%7.9M	---8.2M	--26.84M
End cash Position	27.58%36.55M	--36.55M	--28.65M
Free cash flow	-103.93%-29.73M	---8.08M	---14.58M
Currency Unit	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall